Description
Retatrutide (CAS: 2381089-83-2) (GLP3-R), also designated LY3437943, is a synthetic triple-receptor agonist peptide supplied by AusPepLabs for laboratory and analytical research applications. Each vial is independently verified to ≥99% HPLC purity with a Certificate of Analysis available on request. For scientific research use only.
Why Research Laboratories Select Retatrutide
Retatrutide is one of the most studied triple-receptor agonist peptides in current metabolic research. Its simultaneous engagement of GLP-1, GIP, and glucagon receptors makes it a valuable reference compound for laboratories investigating multi-pathway receptor biology, energy homeostasis models, and metabolic signaling in preclinical settings.
- Triple receptor profile – GLP-1R, GIPR, and GCGR simultaneous engagement in research models
- Referenced extensively in peer-reviewed literature since Phase 2 trial publications in 2023
- Useful for comparative studies alongside single and dual agonist reference compounds
- Lyophilized format ensures stability and reproducibility across experimental runs

Reviews
There are no reviews yet.